We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Community Health Sustain Growth as Elective Demand Softens?
Read MoreHide Full Article
Key Takeaways
CYH's same-store revenues rose 2.4%, but uninsured admissions limited the revenue benefit.
Softer elective surgeries and payer mix pressured revenue per admission and adjusted EBITDA.
CYH expects 2026 revenues of $11.4-$11.6 billion and adjusted EBITDA of $1.30-$1.375 billion.
Community Health Systems, Inc. (CYH - Free Report) is delivering volume growth, but sustaining that momentum will depend on a recovery in commercially insured elective procedures and a better payer mix. In the second quarter of 2026, same-store net revenues increased 2.4% year over year, while adjusted admissions rose 2.9%. However, roughly half of that admission growth came from uninsured patients, limiting the revenue benefit. Same-store net revenue per adjusted admission declined 0.5%, reflecting weaker service and payer mix.
Elective procedures remain the key swing factor. Same-store surgeries declined 0.1%, with inpatient surgeries down 3.8%. Orthopedic procedures, including hip, knee and shoulder replacements, remained soft as patients deferred care amid affordability concerns. Cardiac procedures also remained under pressure. Still, June surgery volumes improved, while clinic visits and orthopedic MRI activity stayed strong, suggesting some demand has been delayed rather than lost.
Unfavorable mix and higher uncompensated care pressured margins. Adjusted EBITDA declined to $330 million in the second quarter from $380 million a year earlier, also reflecting divestitures and differences in state-directed payment benefits. Higher medical specialist fees, particularly anesthesia and radiology, added pressure. Operating cash flow was $87 million, although slower payer payments weighed on receivables.
CYH now expects 2026 revenues of $11.4-$11.6 billion and adjusted EBITDA of $1.30-$1.375 billion. Better elective volumes and payer mix could support performance, while improved reimbursement timing could ease working-capital pressure and strengthen cash generation. The company’s ability to manage specialist labor costs will remain important for margin recovery.
Peer Performance
Community Health Systems’ healthcare peers, including HCA Healthcare, Inc. (HCA - Free Report) and Tenet Healthcare Corporation (THC - Free Report) , also reported solid volume trends, with revenue performance highlighting the importance of payer mix and procedure intensity.
HCA Healthcare is seeing steady volume growth across its hospital network. Same-facility admissions increased 2.5%, while equivalent admissions rose 2.7%. HCA’s revenue per equivalent admission increased 6.4%, despite continued pressure on surgical volumes.
Tenet Healthcare delivered stronger revenue and profitability growth. Net operating revenues increased 6%, while same-hospital net patient service revenue per adjusted admission rose 3.3%. THC’s total surgeries were broadly stable, with inpatient procedures declining 1.4% and outpatient procedures increasing 1%.
CYH’s Price Performance, Valuation & Estimates
Shares of Community Health Systems have lost 9.4% over the past year against the industry's 9% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, CYH trades at a forward price-to-sales of 0.04X, down from the industry average of 0.74X. CYH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CYH’s 2026 loss is pegged at 86 cents per share, followed by 22.9% growth next year.
View the Zacks #1 Rank List
Image: Bigstock
Can Community Health Sustain Growth as Elective Demand Softens?
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) is delivering volume growth, but sustaining that momentum will depend on a recovery in commercially insured elective procedures and a better payer mix. In the second quarter of 2026, same-store net revenues increased 2.4% year over year, while adjusted admissions rose 2.9%. However, roughly half of that admission growth came from uninsured patients, limiting the revenue benefit. Same-store net revenue per adjusted admission declined 0.5%, reflecting weaker service and payer mix.
Elective procedures remain the key swing factor. Same-store surgeries declined 0.1%, with inpatient surgeries down 3.8%. Orthopedic procedures, including hip, knee and shoulder replacements, remained soft as patients deferred care amid affordability concerns. Cardiac procedures also remained under pressure. Still, June surgery volumes improved, while clinic visits and orthopedic MRI activity stayed strong, suggesting some demand has been delayed rather than lost.
Unfavorable mix and higher uncompensated care pressured margins. Adjusted EBITDA declined to $330 million in the second quarter from $380 million a year earlier, also reflecting divestitures and differences in state-directed payment benefits. Higher medical specialist fees, particularly anesthesia and radiology, added pressure. Operating cash flow was $87 million, although slower payer payments weighed on receivables.
CYH now expects 2026 revenues of $11.4-$11.6 billion and adjusted EBITDA of $1.30-$1.375 billion. Better elective volumes and payer mix could support performance, while improved reimbursement timing could ease working-capital pressure and strengthen cash generation. The company’s ability to manage specialist labor costs will remain important for margin recovery.
Peer Performance
Community Health Systems’ healthcare peers, including HCA Healthcare, Inc. (HCA - Free Report) and Tenet Healthcare Corporation (THC - Free Report) , also reported solid volume trends, with revenue performance highlighting the importance of payer mix and procedure intensity.
HCA Healthcare is seeing steady volume growth across its hospital network. Same-facility admissions increased 2.5%, while equivalent admissions rose 2.7%. HCA’s revenue per equivalent admission increased 6.4%, despite continued pressure on surgical volumes.
Tenet Healthcare delivered stronger revenue and profitability growth. Net operating revenues increased 6%, while same-hospital net patient service revenue per adjusted admission rose 3.3%. THC’s total surgeries were broadly stable, with inpatient procedures declining 1.4% and outpatient procedures increasing 1%.
CYH’s Price Performance, Valuation & Estimates
Shares of Community Health Systems have lost 9.4% over the past year against the industry's 9% growth over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, CYH trades at a forward price-to-sales of 0.04X, down from the industry average of 0.74X. CYH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CYH’s 2026 loss is pegged at 86 cents per share, followed by 22.9% growth next year.
Image Source: Zacks Investment Research
CYH currently has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.